Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for ...
Rapport Therapeutics (RAPP) announced two encore poster presentations at the 2025 American Academy of Neurology, AAN, Annual Meeting, taking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback